A separate study using AAV to introduce NeuroD1 under the GFAP promoter ten days post-stroke revealed successful reprogramming of astrocytes into functional neurons with significant improvement in both motor and cognitive functions two months post-treatment [17]. This evidence concerns the gene NEUROD1 and stroke disorder.